By systematic tuning of the components of the electrolyte, the performances of dye-sensitized solar cells (DSCs) with an N-heterocyclic carbene iron(II) dye have been significantly improved. The beneficial effects of an increased Li+ ion concentration in the electrolyte lead to photoconversion efficiencies (PCEs) up to 0.66% for fully masked cells (representing 11.8% relative to 100% set for N719) and an external quantum efficiency maximum (EQEmax) up to approximately 25% due to an increased short-circuit current density (JSC). A study of the effects of varying the length of the alkyl chain in 1-alkyl-3-methylimidazolium iodide ionic liquids (ILs) shows that a longer chain results in an increase in JSC with an overall efficiency up to 0.61% (10.9% relative to N719 set at 100%) on going from n-methyl to n-butyl chain, although an n-hexyl chain leads to no further gain in PCE. The results of electrochemical impedance spectroscopy (EIS) support the trends in JSC and open-circuit voltage (VOC) parameters. A change in the counterion from I− to [BF4]− for 1-propyl-3-methylimidazolium iodide ionic liquid leads to DSCs with a remarkably high JSC value for an N-heterocyclic carbene iron(II) dye of 4.90 mA cm−2, but a low VOC of 244 mV. Our investigations have shown that an increased concentration of Li+ in combination with an optimized alkyl chain length in the 1-alkyl-3-methylimidazolium iodide IL in the electrolyte leads to iron(II)-sensitized DSC performances comparable with those of containing some copper(I)-based dyes.
DSC photoconversion efficiencies of up to 0.93–0.95% have been achieved for a new heteroleptic iron(ii) N-heterocyclic carbene sensitizer employing n-butyl chains.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.